Atlas Trials

Expanded Access of Pemigatinib to Treat a Single Patient With Metastatic Pancreatic Cancer

Clinical trial NCT03906357 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT03906357
Sponsor
Incyte Corporation
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.